eradication of covid-19 To get out of the world would be difficult. But the development of a more effective preventative vaccine is coming. which will make vaccination against covid like the flu vaccine with injections once a year
Moderna says COVID-19 vaccine trial results The new version was successful. To create immunity 8 times more than the first vaccine to protect against omikron strains. This made it more hopeful that they would only be injected once a year.
The COVID-19 omicron subspecies BA.2 is slightly less vaccinated than BA.1.
urgent! Bang Sue injection center Walk in injection “Moderna” this 8 – 10 June.
new covid vaccine Will be immune to both omikron and the original corona virus. It is expected to be produced in the fall of this year.
Dr. Apol Burton, Head of the Moderna Medical Office It said the new vaccine would greatly increase the level of omikron immunity. This makes vaccination once a year is enough to prevent. And it may not be necessary to develop new vaccines even if mutations occur.
“The information obtained today suggests that the resistance against Omikron And for the first time we’re having a yearly vaccine.”
Moderna’s new vaccine, mRNA1273.214, contains the first-generation Moderna vaccine. with vaccines directed at 25 micrograms of omikron each, which from the experiments in the sample considered to be effective
Moderna has not released a full report from the trial. But Moderna claims that people who were vaccinated had an 8-fold increase in omicron immunity in the first four weeks.
Burton claimed that a resistance level of more than 400 units was sufficient to resist. But from testing people who have never been infected before Immune to 6,000 units and people who have been infected Immune up to 9,500 units.
First mutant tomicron The BA.1 strain started to spread last year. and caused an epidemic all over the world. although the symptoms are less common than the previous strains. But the infection spreads faster. and causing increased morbidity and mortality
Since the first omikron outbreak, in December and January in England, a subspecies have emerged. which spreads faster, called BA.2, then there are subspecies BA.4 and BA.5
Despite the mutation But Dr. Burton Confident that the vaccine will protect against all subspecies of omikron. and will build good immunity in the long run
Moderna to seek approval from the US Food and Drug Administration including in England and Europe which, if approved, is expected to be produced in the fall of this year.